下周，持股待涨，但需警惕1个风险

Market Overview - The market exhibited a volatile upward trend this week, with growth styles significantly outperforming value sectors, indicating an increase in trading activity and capital inflow willingness [1] - Major indices strengthened, led by technology growth sectors, reflecting heightened market attention on high-prosperity tracks [1][2] - A-share market saw the Shanghai Composite Index rise by 1.7% to 3696.77 points, marking a new weekly high since 2022, while the Shenzhen Component Index increased by 4.55% and the ChiNext Index surged by 8.84% [2] Sector Performance - In the A-share market, the communication sector rose by 7.66%, driven by surging AI computing demand, while the electronics sector increased by 7.02% due to a 20% year-on-year growth in global semiconductor sales [4] - The financial sector benefited from active market trading and policy expectations, contributing to the overall market's upward momentum [1] - In the Hong Kong market, healthcare, raw materials, and information technology sectors all saw gains exceeding 4%, with the healthcare sector specifically rising by 7.27% [4] Capital Flow and Market Sentiment - The capital market showed positive signals, with weekly trading volume and margin financing balances both surpassing recent highs, indicating strong support for the market [1] - The influx of incremental capital has enhanced market resilience, with the two financing balances exceeding 2 trillion yuan, reflecting renewed confidence in leveraged funds [6] Future Outlook - The A-share market is expected to maintain its strong momentum, with a continued upward trend anticipated, although caution is advised regarding potential profit-taking pressures at high levels [6] - The technology growth sector is projected to sustain high elasticity due to industry trends and policy support, particularly in AI computing infrastructure and semiconductor sectors [6] - Mid-term strategies should focus on AI computing, breakthroughs in new energy technologies, and innovative pharmaceuticals, while also considering defensive positions in traditional sectors [6]